PBS News reports that cost remains a major barrier for many patients, even after some recent improvements in GLP-1 access.
Recap by typeshit. Video by pbsnews on TikTok.
Ireland's drug pricing body recommended semaglutide over tirzepatide for cost reasons, and Higgins says it's the right call, with a pun he didn't get to use.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
Avi Roy puts last year's sales of the two shots at $71B, roughly four times the $18B he says the two AI labs brought in.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Speaking to People, she also recalls asking her dad Ozzy for help while she was struggling. The interview has the rest.
A new review in Cureus pulls together efficacy and safety evidence on orforglipron, the daily pill alternative to injectable GLP-1 drugs.
Loading…